Literature DB >> 14634878

Stereotactic aspiration and fibrinolysis of spontaneous supratentorial intracerebral hematomas versus conservative treatment: a matched-pair study.

W Deinsberger1, C Lang, C Hornig, D K Boeker.   

Abstract

OBJECTIVES: Since introduction of stereotactic aspiration and fibrinolysis into the treatment of deep-seated intracerebral hematomas by Hondo and Matsumoto 1984 this method has become widely used, and satisfactory morphological results are achieved. Nevertheless, whether the outcome is improved has not yet been investigated. MATERIAL AND
METHOD: 17 patients with spontaneous intracerebral hematomas have been treated surgically; after angiographic exclusion of a vascular malformation stereotactic aspiration and fibrinolysis with 3 mg rTPA was performed. Between 1992 and 1995 104 patients were treated conservatively according to best medical treatment. From this group "matched pairs" with the surgical patients were set up concurring in primary (consciousness, size and location of the hematoma) and secondary parameters (age, sex, ventricular hemorrhage). Endpoint of the study was the Glasgow outcome score (GOS) six months after treatment. Data were analyzed statistically and p < 0.05 was considered significant.
RESULTS: In respect of primary parameters complete concurrence and regarding secondary parameters far-reaching concurrence was achieved. In no parameter the surgical and conservative group were significantly different from each other. Six months after the ictus no significant difference between surgical and conservative treatment concerning GOS could be established.
CONCLUSION: These results indicate that patients do not benefit from stereotactic aspiration and fibrinolysis of putamenal hematomas. For a final treatment recommendation a prospective randomised trial is required.

Entities:  

Mesh:

Year:  2003        PMID: 14634878     DOI: 10.1055/s-2003-44617

Source DB:  PubMed          Journal:  Zentralbl Neurochir        ISSN: 0044-4251


  7 in total

1.  Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage.

Authors:  Ryan J Barrett; Rahat Hussain; William M Coplin; Samera Berry; Penelope M Keyl; Daniel F Hanley; Robert R Johnson; J Ricardo Carhuapoma
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage.

Authors:  Ruth Thiex; Veit Rohde; Ina Rohde; Lothar Mayfrank; Zeliha Zeki; Armin Thron; Joachim M Gilsbach; Eberhard Uhl
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

3.  Heme oxygenase 1 plays role of neuron-protection by regulating Nrf2-ARE signaling post intracerebral hemorrhage.

Authors:  Xiao-Ping Yin; Dan Wu; Jun Zhou; Zhi-Ying Chen; Bing Bao; Liang Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Effects of that ATRA inhibits Nrf2-ARE pathway on glial cells activation after intracerebral hemorrhage.

Authors:  Xiao-Ping Yin; Jun Zhou; Dan Wu; Zhi-Ying Chen; Bing Bao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.

Authors:  J Ricardo Carhuapoma; Ryan J Barrett; Penelope M Keyl; Daniel F Hanley; Robert R Johnson
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

6.  Surgical vs. Conservative Management for Lobar Intracerebral Hemorrhage, a Meta-Analysis of Randomized Controlled Trials.

Authors:  Muhammad Junaid Akram; Rui Zhao; Xue Shen; Wen-Song Yang; Lan Deng; Zuo-Qiao Li; Xiao Hu; Li-Bo Zhao; Peng Xie; Qi Li
Journal:  Front Neurol       Date:  2022-01-20       Impact factor: 4.003

7.  Mechanisms underlying the perifocal neuroprotective effect of the Nrf2-ARE signaling pathway after intracranial hemorrhage.

Authors:  Xiao-Ping Yin; Zhi-Ying Chen; Jun Zhou; Dan Wu; Bing Bao
Journal:  Drug Des Devel Ther       Date:  2015-11-17       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.